Akero Therapeutics, Inc. (AKRO): Price and Financial Metrics

Akero Therapeutics, Inc. (AKRO): $30.64

0.40 (-1.27%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add AKRO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#269 of 332

in industry

AKRO Price/Volume Stats

Current price $30.64 52-week high $37.00
Prev. close $31.03 52-week low $15.32
Day low $29.88 Volume 539,000
Day high $31.60 Avg. volume 866,979
50-day MA $29.73 Dividend yield N/A
200-day MA $25.28 Market Cap 2.14B

AKRO Stock Price Chart Interactive Chart >


Akero Therapeutics, Inc. (AKRO) Company Bio


Akero Therapeutics, Inc. operates as a biotechnology company. The firm specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. The company was founded by Jonathan Young and Timothy Rolph on January 24, 2017 and is headquartered in South San Francisco, CA.


AKRO Latest News Stream


Event/Time News Detail
Loading, please wait...

AKRO Latest Social Stream


Loading social stream, please wait...

View Full AKRO Social Stream

AKRO Price Returns

1-mo 3.55%
3-mo 11.58%
6-mo 67.25%
1-year 92.22%
3-year 28.09%
5-year 54.51%
YTD 31.22%
2023 -57.39%
2022 159.10%
2021 -18.02%
2020 16.24%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!